AlphAIalphai — Financial news for AI agents
SEC EDGAR 8-KAUG 45 min read$BXC

BlueLinx Holdings Inc. (BXC): Results of Operations and Financial Condition

BlueLinx Holdings Inc. (BXC) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 q22026earnings991.htm EX-99.1 Document Exhibit 99.1 BlueLinx Announces Second Quarter 2026 Results ATLANTA, August 4, 2026 – BlueLinx Holdings Inc. (NYSE: BXC), a leading U.S. wholesale distributor of building products, today reported financial results for the fiscal th

Original reporting
SEC EDGAR 8-K
Published Aug 4, 2026, 8:14 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 4, 2026, 8:19 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About alphai AI DeskScoring methodologyReport an issue
alphai market briefEarnings
Primary signal
$BXC
Bullish
medium confidence
Mentioned
$BXC
Relevance
7/10
alphai data visualization · based on SEC EDGAR 8-K
Decision brief

The 30-second read

$BXCBullishMed
01

Why it matters

Traders can update near-term expectations using the disclosed Q2 profitability metrics, free cash flow improvement, and segment gross-margin guidance for Q3 2026.

02

Market read

The filing provides a full earnings-style datapoint set (sales, gross margin, adjusted EBITDA, free cash flow) and explicit Q3 gross-margin ranges, which can move estimates and positioning ahead of the conference call.

03

What to watch

SG&A rose $12.1M YoY due to Disdero acquisition and logistics costs, so investors should watch whether margin gains persist without one-off duty benefits.

Relevance 7/10Novelty 8/10Timing: after-hours filing on Aug 4, 2026, ahead of the Aug 5 conference call

Background

This is BlueLinx’s SEC 8-K (Item 2.02) reporting second quarter 2026 results for the fiscal three months ended July 4, 2026, plus capital position and Q3 outlook.

Company-level read

Ticker impact

$BXCBullishMedium confidence
Context

BlueLinx reported Q2 2026 net sales of $814M (+4.4% YoY) and raised profitability, with adjusted EBITDA up 33% YoY.

Expected impact

Near-term bias to the upside if investors focus on margin expansion and improved free cash flow, with attention on whether Q3 gross margins land in the guided ranges.

Evidence & confidence

The filing includes multiple fresh datapoints (sales, gross margin, adjusted EBITDA, free cash flow improvement) plus explicit Q3 gross-margin ranges, which can drive estimate revisions and positioning.

Market effects

Sector

Wholesale building-products distributors may see read-through on demand and pricing power via segment gross-margin trends.

Regional

Primarily US-focused distribution performance could influence sentiment toward US construction supply chains.

Global

Limited direct global linkage, except for the disclosed import duty-related item affecting gross margin.

Counterpoint

What could challenge this read

Gross margin improvement includes a $7.2M import duty-related benefit; excluding it, margins and adjusted EBITDA are less strong.

Key entities

  • company
    BlueLinx Holdings Inc.

    Wholesale distributor of building products; reported Q2 2026 results and provided Q3 gross-margin guidance.

  • acquisition
    Disdero Lumber Co., LLC

    Acquisition referenced as contributing to specialty product net sales growth and gross profit.

Read at source← All news

Related articles

AUG 11
$CLXMedAI 8/10

Clorox (CLX) Q4 2026 Earnings Call Transcript

Clorox (CLX) reported Q4 FY2026 net sales of $1.95B, down 2% (GOJO added about 10 points). Organic sales fell 13% and adjusted EPS was $1.66, down 42%. Gross margin was 41.3%. For FY2027, it guided organic sales growth of 3.5% to 4.5% and adjusted EPS of $5.70 to $6.00, citing inflation headwinds of $200M+.

fool.com6 min
AUG 11
$FMSMedAI 8/10

Fresenius Medical Care (FMS) Q2 2026 Earnings Call Transcript

Fresenius Medical Care (FMS) reported Q2 2026 revenue of EUR 4,861 million, up 5% organically, and adjusted operating income of EUR 569 million (+23% at constant currency). Adjusted basic EPS was EUR 1.13 (+28% constant currency). Management reaffirmed broadly flat 2026 revenue and operating income growth, citing U.S. referral execution issues and China regulatory headwinds.

fool.com6 min
AUG 11
$TTIMedAI 8/10

TETRA (TTI) Q2 2026 Earnings Call Transcript

TETRA Technologies (TTI) reported Q2 2026 revenue of $185.7 million, up 19% sequentially and 7% year over year, and adjusted EBITDA of $31.9 million. The company said international offshore revenues hit a 10-year high and that an equity offering reduced net debt to $28.7 million and net leverage to 0.4x. It also approved the Arkansas bromine project, with startup in early 2028.

fool.com6 min
AUG 11
$KOPNHighAI 9/10

Why is Kopin stock surging today?

Kopin Corp (KOPN) shares rose about 26% after the company reported Q2 2026 results above expectations, with revenue of $12.7M versus $11.75M consensus and net income of $0.9M versus a $5.2M loss a year earlier. Kopin also guided to full GAAP profitability by Q4 2026 and said its Neural I/o MicroLED optical interconnect with Fabric.AI remains on track for a CES 2027 demo.

investing.com3 min
AUG 11
$CHRWMed

C.H. Robinson reports 20% increase in adjusted operating income

C.H. Robinson (CHRW) said Q2 2026 adjusted operating income rose 20% year over year as its transformation continued amid weaker freight demand. It reported NAST operating margin (ex restructuring) up 280 bps to 40.9% and Global Forwarding up 470 bps to 33.4%. The company returned $301 million via dividends and buybacks.

freshplaza.com4 min